We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Histology Reveals Characteristics of Superimposed Bacterial Ulcerative Colitis

By LabMedica International staff writers
Posted on 23 Jan 2014
Biopsy specimens have been examined for histologic features suggestive of Clostridium difficile infection in patients with ulcerative colitis.

In patients with acutely symptomatic ulcerative colitis, it is important to determine whether the underlying cause of the disease is due to a C. More...
difficile infection or may arise due to other infectious organisms and or bowel ischemia.

Pathologists at St Michael’s Hospital (Toronto, ON, Canada) examined nine patients with ulcerative colitis who had colonic biopsy specimens taken during a symptomatic flare that coincided with positive C. difficile (C. difficile+) tests. They also examined 28 controls that were biopsied during an ulcerative colitis flare, but tested negative for C. difficile. The scientists reviewed the histological slides for evidence of pseudomembranes, ischemic-like changes, degree of colitis, and lamina propria hemorrhage. Pseudomembranes are not real membranes: they represent necrotic debris attached to the colonic wall and may vaguely resemble a volcanic eruption, when examined microscopically.

Stool testing was performed using the C. difficile Tox A/B II enzyme immunoassay (EIA) (Techlab; Blacksburg, VA, USA). The results were analyzed with a dual-wavelength spectrometer at 450 nm and 620 nm. In the patients who had a positive C. difficile+ test, four of nine (44.4%) had microscopic pseudomembranes compared with only 11% in controls who were C. difficile negative, which was statistically significant. The investigators found that other histologic and clinical features were not predictive.

The authors concluded that although the presence of microscopic pseudomembranes suggests C. difficile infection in patients with ulcerative colitis, sensitivity and specificity were poor; biopsy findings do not reliably detect this infection in patients with ulcerative colitis. However, the authors propose that histologic findings of microscopic pseudomembranes should also prompt testing for C. difficile if not already performed.

Ulcerative colitis is a form of inflammatory bowel disease (IBD). It is a disease of the colon that includes characteristic ulcers, or open sores. The main symptom of active disease is usually constant diarrhea mixed with blood, of gradual onset. IBD is often confused with irritable bowel syndrome. The study was published in the December 2013 issue of the American Journal of Clinical Pathology.

Related Links:

St Michael’s Hospital
Techlab



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.